Literature DB >> 23747726

Identification of HDAC4 as a target of γ-catenin that regulates the oncogenic K-Ras-mediated malignant phenotype of Rat2 cells.

Ji-Hye Yim1, Jeong-Hwa Baek, Chang-Woo Lee, Min-Jung Kim, Hong Shik Yun, Eun-Hee Hong, Su-Jae Lee, Jong Kuk Park, Hong-Duck Um, Sang-Gu Hwang.   

Abstract

The mechanisms by which activated Ras accelerates malignant transformation of normal cells are not fully understood. Here, we characterized the role and molecular mechanism of γ-catenin in regulating the malignant phenotype of Rat2 cells induced by codon 12-mutant K-Ras (K-Ras12V). Suppression of γ-catenin signaling by K-Ras12V was an early event and played a crucial role in promoting the acquisition of a highly metastatic phenotype of Rat2 cells. Notably, the gene encoding histone deacetylase 4 (HDAC4) was identified as a target of γ-catenin during this process. The transcription factor, lymphoid enhancer-binding factor-1 (Lef1), was involved in the modulation of HDAC4 transcription, and disruption of this pathway was a key event in promoting the invasion and migration of K-Ras12V-transduced Rat2 cells. Thus, our findings extend the range of targets for the development of new drugs for the therapy of oncogenic K-Ras-driven cancer.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HDAC4; Lef1; Oncogenic K-Ras; Rat2 fibroblast cells; γ-Catenin

Mesh:

Substances:

Year:  2013        PMID: 23747726     DOI: 10.1016/j.bbrc.2013.05.122

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis.

Authors:  Zackie Aktary; Mahsa Alaee; Manijeh Pasdar
Journal:  Oncotarget       Date:  2017-05-09

2.  Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.

Authors:  Zackie Aktary; Manijeh Pasdar
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.